{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T06:54:03Z","timestamp":1768200843280,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T00:00:00Z","timestamp":1572912000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T00:00:00Z","timestamp":1572912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00277-019-03826-4","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T03:03:44Z","timestamp":1572923024000},"page":"2693-2701","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Magnetic resonance imaging reveals distinct bone marrow patterns in indolent and advanced systemic mastocytosis"],"prefix":"10.1007","volume":"98","author":[{"given":"Philipp","family":"Riffel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"Jawhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Gawlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Schwaab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik J.","family":"Michaely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia","family":"Metzgeroth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolf-Karsten","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan O.","family":"Schoenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,5]]},"reference":[{"key":"3826_CR1","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1182\/blood-2007-11-078097","volume":"112","author":"DD Metcalfe","year":"2008","unstructured":"Metcalfe DD (2008) Mast cells and mastocytosis. Blood 112:946\u2013956","journal-title":"Blood"},{"key":"3826_CR2","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1046\/j.1365-2141.2003.04575.x","volume":"122","author":"P Valent","year":"2003","unstructured":"Valent P, Akin C, Sperr WR, Horny HP, Arock M, Lechner K, Bennett JM, Metcalfe DD (2003) Diagnosis and treatment of systemic mastocytosis: state of the art. Br J Haematol 122:695\u2013717","journal-title":"Br J Haematol"},{"key":"3826_CR3","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/S0046-8177(85)80252-5","volume":"16","author":"HP Horny","year":"1985","unstructured":"Horny HP, Parwaresch MR, Lennert K (1985) Bone marrow findings in systemic mastocytosis. Hum Pathol 16:808\u2013814","journal-title":"Hum Pathol"},{"key":"3826_CR4","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R et al (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127:2391\u20132405","journal-title":"Blood"},{"key":"3826_CR5","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","volume":"129","author":"P Valent","year":"2017","unstructured":"Valent P, Akin C, Metcalfe DD (2017) Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts. Blood 129:1420\u20131427","journal-title":"Blood"},{"issue":"1","key":"3826_CR6","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1002\/ajh.25302","volume":"94","author":"Ayalew Tefferi","year":"2018","unstructured":"Tefferi A, Shah S, Reichard KK, Hanson CA, Pardanani A (2018) Smouldering mastocytosis: survival comparisons with indolent and aggressive mastocytosis. Am J Hematol. \nhttps:\/\/doi.org\/10.1002\/ajh.25302","journal-title":"American Journal of Hematology"},{"key":"3826_CR7","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1002\/ajh.24553","volume":"91","author":"A Pardanani","year":"2016","unstructured":"Pardanani A (2016) Systemic mastocytosis in adults: 2017 update on diagnosis, risk stratification and management. Am J Hematol 91:1146\u20131159","journal-title":"Am J Hematol"},{"key":"3826_CR8","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3324\/haematol.2017.163964","volume":"102","author":"M Jawhar","year":"2017","unstructured":"Jawhar M, Schwaab J, Meggendorfer M, Naumann N, Horny HP, Sotlar K, Haferlach T, Schmitt K, Fabarius A, Valent P, Hofmann WK, Cross NCP, Metzgeroth G, Reiter A (2017) The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasm. Haematologica 102:1035\u20131043","journal-title":"Haematologica"},{"key":"3826_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1182\/blood-2017-01-764423","volume":"130","author":"M Jawhar","year":"2017","unstructured":"Jawhar M, Schwaab J, Naumann N, Horny HP, Sotlar K, Haferlach T, Metzgeroth G, Fabarius A, Valent P, Hofmann WK, Cross NCP, Meggendorfer M, Reiter A (2017) Response and progression on midostaurin in advanced systemic mastocytosis: KIT D816V and other molecular markers. Blood 130:137\u2013145","journal-title":"Blood"},{"key":"3826_CR10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/leu.2015.284","volume":"30","author":"M Jawhar","year":"2016","unstructured":"Jawhar M, Schwaab J, Schnittger S, Meggendorfer M, Pfirrmann M, Sotlar K, Horny HP, Metzgeroth G, Kluger S, Naumann N, Haferlach C, Haferlach T, Valent P, Hofmann WK, Fabarius A, Cross NC, Reiter A (2016) Additional mutations in SRSF2, ASXL1 and\/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis. Leukemia 30:136\u2013143","journal-title":"Leukemia"},{"key":"3826_CR11","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1038\/leu.2016.190","volume":"30","author":"M Jawhar","year":"2016","unstructured":"Jawhar M, Schwaab J, Hausmann D, Clemens J, Naumann N, Henzler T, Horny HP, Sotlar K, Schoenberg SO, Cross NC, Fabarius A, Hofmann WK, Valent P, Metzgeroth G, Reiter A (2016) Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2\/ASXL1\/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis. Leukemia 30:2342\u20132350","journal-title":"Leukemia"},{"key":"3826_CR12","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1182\/blood-2013-04-496448","volume":"122","author":"J Schwaab","year":"2013","unstructured":"Schwaab J, Schnittger S, Sotlar K, Walz C, Fabarius A, Pfirrmann M, Kohlmann A, Grossmann V, Meggendorfer M, Horny HP, Valent P, Jawhar M, Teichmann M, Metzgeroth G, Erben P, Ernst T, Hochhaus A, Haferlach T, Hofmann WK, Cross NC, Reiter A (2013) Comprehensive mutational profiling in advanced systemic mastocytosis. Blood 122:2460\u20132466","journal-title":"Blood"},{"key":"3826_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2141.2006.06306.x","volume":"136","author":"G Metzgeroth","year":"2007","unstructured":"Metzgeroth G, Dinter D, Erben P, La Rosee P, Hehlmann R, Hastka J (2007) Systemic mastocytosis simulating osseous metastatic disease. Br J Haematol 136:1","journal-title":"Br J Haematol"},{"key":"3826_CR14","doi-asserted-by":"publisher","DOI":"10.1056\/ENEJMicm010831","volume":"349","author":"A Deb","year":"2003","unstructured":"Deb A, Tefferi A (2003) Images in clinical medicine. Systemic mastocytosis N Engl J Med 349:e7","journal-title":"Systemic mastocytosis N Engl J Med"},{"key":"3826_CR15","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1046\/j.1365-2141.2003.04416.x","volume":"122","author":"B Myers","year":"2003","unstructured":"Myers B, Grimley C, Jones SG, Clark D, Kerslake R (2003) Skin, bone marrow and magnetic resonance imaging appearances in systemic mastocytosis. Br J Haematol 122:876","journal-title":"Br J Haematol"},{"key":"3826_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.clinimag.2017.05.003","volume":"44","author":"Y Epelboym","year":"2017","unstructured":"Epelboym Y, Keraliya AR, Tirumani SH, Hornick JL, Ramaiya NH, Shinagare AB (2017) Differences in the imaging features and distribution of non-indolent and indolent mastocytosis: a single institution experience of 29 patients. Clin Imaging 44:111\u2013116","journal-title":"Clin Imaging"},{"key":"3826_CR17","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1259\/0007-1285-60-716-765","volume":"60","author":"TY Huang","year":"1987","unstructured":"Huang TY, Yam LT, Li CY (1987) Radiological features of systemic mast-cell disease. Br J Radiol 60:765\u2013770","journal-title":"Br J Radiol"},{"key":"3826_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s002560050350","volume":"27","author":"NA Avila","year":"1998","unstructured":"Avila NA, Ling A, Metcalfe DD, Worobec AS (1998) Mastocytosis: magnetic resonance imaging patterns of marrow disease. Skelet Radiol 27:119\u2013126","journal-title":"Skelet Radiol"},{"key":"3826_CR19","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1007\/s003300050796","volume":"9","author":"M Roca","year":"1999","unstructured":"Roca M, Mota J, Giraldo P, Garcia Erce JA (1999) Systemic mastocytosis: MRI of bone marrow involvement. Eur Radiol 9:1094\u20131097","journal-title":"Eur Radiol"},{"key":"3826_CR20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0899-7071(99)00146-1","volume":"23","author":"S Siegel","year":"1999","unstructured":"Siegel S, Sadler MA, Yook C, Chang V, Miller J (1999) Systemic mastocytosis with involvement of the pelvis: a radiographic and clinicopathologic study--a case report. Clin Imaging 23:245\u2013248","journal-title":"Clin Imaging"},{"key":"3826_CR21","unstructured":"Di Leo C, Lodi A, Pozzato C et al (2003) Systemic mastocytosis: bone marrow involvement assessed by Tc-99m MDP scintigraphy and magnetic resonance imaging. Haematologica 88:Ecr26"},{"key":"3826_CR22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1586\/ehm.12.12","volume":"5","author":"WR Sperr","year":"2012","unstructured":"Sperr WR, Valent P (2012) Diagnosis, progression patterns and prognostication in mastocytosis. Expert Rev Hematol 5:261\u2013274","journal-title":"Expert Rev Hematol"},{"key":"3826_CR23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/00005792-198811000-00001","volume":"67","author":"WD Travis","year":"1988","unstructured":"Travis WD, Li CY, Bergstralh EJ, Yam LT, Swee RG (1988) Systemic mast cell disease. Analysis of 58 cases and literature review. Medicine (Baltimore) 67:345\u2013368","journal-title":"Medicine (Baltimore)"},{"key":"3826_CR24","first-page":"170","volume":"129","author":"P Armingaud","year":"2002","unstructured":"Armingaud P, Zerkak D, Lespessailles E et al (2002) Bone evaluation in ten adults with cutaneous mastocytosis. Ann Dermatol Venereol 129:170\u2013172","journal-title":"Ann Dermatol Venereol"},{"key":"3826_CR25","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/S0140-6736(05)70467-0","volume":"350","author":"T Grieser","year":"1997","unstructured":"Grieser T, Minne HW (1997) Systemic mastocytosis and skeletal lesions. Lancet 350:1103\u20131104","journal-title":"Lancet"},{"key":"3826_CR26","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1359\/jbmr.2002.17.4.567","volume":"17","author":"C Brumsen","year":"2002","unstructured":"Brumsen C, Hamdy NA, Papapoulos SE (2002) Osteoporosis and bone marrow mastocytosis: dissociation of skeletal responses and mast cell activity during long-term bisphosphonate therapy. J Bone Miner Res 17:567\u2013569","journal-title":"J Bone Miner Res"},{"key":"3826_CR27","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1136\/ard.2004.029116","volume":"64","author":"AY Lim","year":"2005","unstructured":"Lim AY, Ostor AJ, Love S, Crisp AJ (2005) Systemic mastocytosis: a rare cause of osteoporosis and its response to bisphosphonate treatment. Ann Rheum Dis 64:965\u2013966","journal-title":"Ann Rheum Dis"},{"key":"3826_CR28","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/eci.12607","volume":"46","author":"M Jawhar","year":"2016","unstructured":"Jawhar M, Schwaab J, Horny HP, Sotlar K, Naumann N, Fabarius A, Valent P, Cross NC, Hofmann WK, Metzgeroth G, Reiter A (2016) Impact of centralized evaluation of bone marrow histology in systemic mastocytosis. Eur J Clin Investig 46:392\u2013397","journal-title":"Eur J Clin Investig"},{"key":"3826_CR29","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1136\/ard.2009.124511","volume":"69","author":"S Barete","year":"2010","unstructured":"Barete S, Assous N, de Gennes C, Grandpeix C, Feger F, Palmerini F, Dubreuil P, Arock M, Roux C, Launay JM, Fraitag S, Canioni D, Billemont B, Suarez F, Lanternier F, Lortholary O, Hermine O, Franc\u00e8s C (2010) Systemic mastocytosis and bone involvement in a cohort of 75 patients. Ann Rheum Dis 69:1838\u20131841","journal-title":"Ann Rheum Dis"},{"key":"3826_CR30","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1056\/NEJM199202273260907","volume":"326","author":"HC Kluin-Nelemans","year":"1992","unstructured":"Kluin-Nelemans HC, Jansen JH, Breukelman H et al (1992) Response to interferon alfa-2b in a patient with systemic mastocytosis. N Engl J Med 326:619\u2013623","journal-title":"N Engl J Med"},{"key":"3826_CR31","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.bone.2011.07.004","volume":"49","author":"M Rossini","year":"2011","unstructured":"Rossini M, Zanotti R, Bonadonna P, Artuso A, Caruso B, Schena D, Vecchiato D, Bonifacio M, Viapiana O, Gatti D, Senna G, Riccio A, Passalacqua G, Pizzolo G, Adami S (2011) Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis. Bone 49:880\u2013885","journal-title":"Bone"},{"key":"3826_CR32","first-page":"97","volume":"28","author":"M Manara","year":"2010","unstructured":"Manara M, Varenna M, Cantoni S, Parafioriti A, Gallazzi MB, Sinigaglia L (2010) Osteoporosis with vertebral fractures in young males, due to bone marrow mastocytosis: a report of two cases. Clin Exp Rheumatol 28:97\u2013100","journal-title":"Clin Exp Rheumatol"},{"key":"3826_CR33","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1159\/000063858","volume":"128","author":"TC Theoharides","year":"2002","unstructured":"Theoharides TC, Boucher W, Spear K (2002) Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol 128:344\u2013350","journal-title":"Int Arch Allergy Immunol"},{"key":"3826_CR34","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.clim.2005.01.011","volume":"115","author":"K Brockow","year":"2005","unstructured":"Brockow K, Akin C, Huber M, Metcalfe DD (2005) IL-6 levels predict disease variant and extent of organ involvement in patients with mastocytosis. Clin Immunol 115:216\u2013223","journal-title":"Clin Immunol"},{"key":"3826_CR35","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/jcp.21468","volume":"216","author":"S Kanzaki","year":"2008","unstructured":"Kanzaki S, Takahashi T, Kanno T, Ariyoshi W, Shinmyouzu K, Tujisawa T, Nishihara T (2008) Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor. J Cell Physiol 216:844\u2013850","journal-title":"J Cell Physiol"},{"key":"3826_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ageing\/25.1.1","volume":"25","author":"C Johansson","year":"1996","unstructured":"Johansson C, Roupe G, Lindstedt G, Mellstrom D (1996) Bone density, bone markers and bone radiological features in mastocytosis. Age Ageing 25:1\u20137","journal-title":"Age Ageing"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03826-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-019-03826-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03826-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:12:29Z","timestamp":1604448749000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-019-03826-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,5]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3826"],"URL":"https:\/\/doi.org\/10.1007\/s00277-019-03826-4","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,5]]},"assertion":[{"value":"12 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}